Germany-based medical technology company Microstim secured series A funding worth €1.5m ($2m) on Thursday from a pool of Germany-based investors including federal state fund Technologiefonds MV, the corporate-backed venture capital fund High-Tech Gründerfonds and Fides Finanz-Invest, a division of the Jasika property group.
High-Tech Gründerfonds previously supplied seed financing to Microstim in February 2009, investing €500,000.
Founded in 2007, Microstim constructs implantable ventricular devices that assist the preservation of the heart’s muscle and tissue function. Microstim plans to use…
